Department of Pharmacology, Tennis Court Road, Cambridge CB2 1PD, UK.
Biochem Biophys Res Commun. 2011 Jul 29;411(2):416-20. doi: 10.1016/j.bbrc.2011.06.168. Epub 2011 Jul 2.
Phosphatidylinositol 4-phosphate 5-kinase Iγ (PIP5KIγ) is subject to extensive C-terminal splice variation, with four variants, PIP5KIγ_v1, 2, 4 and 5, described in humans Schill and Anderson (2009) [7]. Here firstly, we report a new rodent splice variant, which includes the exon that was previously unique to the rodent neuron-specific PIP5KIγ93 Giudici et al. (2006) [6], but which omits the C-terminal exon of PIP5KIγ93; this new variant shows a wide tissue expression pattern in mouse. Secondly, we show that in humans there is an alternative splicing site 78 nucleotides from the start of exon 16c, such that humans additionally express both PIP5KIγ93 (which we now call PIP5KIγ_v3) specifically in brain and, again expressed more widely, the new variant described here, which we now name PIP5KIγ_v6.
磷脂酰肌醇 4,5-二磷酸 5-激酶 Iγ(PIP5KIγ)的 C 端存在广泛的剪接变异,人类中有四种变体,PIP5KIγ_v1、2、4 和 5Schill 和 Anderson(2009)[7]。在这里,我们首先报道了一种新的啮齿动物剪接变体,它包含以前仅存在于啮齿动物神经元特异性 PIP5KIγ93Giudici 等人的外显子(2006)[6],但它省略了 PIP5KIγ93 的 C 端外显子;这种新变体在小鼠中表现出广泛的组织表达模式。其次,我们表明,在人类中,在外显子 16c 的起始处有 78 个核苷酸的替代剪接位点,使得人类特异性地在大脑中表达 PIP5KIγ93(我们现在称为 PIP5KIγ_v3),并且再次更广泛地表达了这里描述的新变体,我们现在将其命名为 PIP5KIγ_v6。